Review



alpha mouse liver 12 aml12 cells  (CLS Cell Lines Service GmbH)


Bioz Verified Symbol CLS Cell Lines Service GmbH is a verified supplier
Bioz Manufacturer Symbol CLS Cell Lines Service GmbH manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    CLS Cell Lines Service GmbH alpha mouse liver 12 aml12 cells
    Alpha Mouse Liver 12 Aml12 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aml12+cells/AML12+Cells/10__1016_slash_j__fbio__2026__109210-48-0-9
    Average 94 stars, based on 6 article reviews
    alpha mouse liver 12 aml12 cells - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    Modification:

    Article Title: Reference Gene Validation for Quantitative PCR Analysis in 2D and 3D AML12 Hepatocyte Models
    Article Snippet: bility for gene-expression analysis in AML12 cells, with particular emphasis on how their stability is influenced by the mode of culture, 2D versus 3D. The hepatic parenchymal cell line AML12 (300643, Cytion, Heidelberg, Germany) was maintained under standard culture conditions in a 1:1 mixture of Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s F12 medium (Cytion, Heidelberg, Germany) supplemen

    Cell Culture:

    Article Title: Reference Gene Validation for Quantitative PCR Analysis in 2D and 3D AML12 Hepatocyte Models
    Article Snippet: bility for gene-expression analysis in AML12 cells, with particular emphasis on how their stability is influenced by the mode of culture, 2D versus 3D. The hepatic parenchymal cell line AML12 (300643, Cytion, Heidelberg, Germany) was maintained under standard culture conditions in a 1:1 mixture of Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s F12 medium (Cytion, Heidelberg, Germany) supplemen

    Labeling:

    Article Title: Reference Gene Validation for Quantitative PCR Analysis in 2D and 3D AML12 Hepatocyte Models
    Article Snippet: bility for gene-expression analysis in AML12 cells, with particular emphasis on how their stability is influenced by the mode of culture, 2D versus 3D. The hepatic parenchymal cell line AML12 (300643, Cytion, Heidelberg, Germany) was maintained under standard culture conditions in a 1:1 mixture of Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s F12 medium (Cytion, Heidelberg, Germany) supplemen

    Incubation:

    Article Title: Reference Gene Validation for Quantitative PCR Analysis in 2D and 3D AML12 Hepatocyte Models
    Article Snippet: bility for gene-expression analysis in AML12 cells, with particular emphasis on how their stability is influenced by the mode of culture, 2D versus 3D. The hepatic parenchymal cell line AML12 (300643, Cytion, Heidelberg, Germany) was maintained under standard culture conditions in a 1:1 mixture of Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s F12 medium (Cytion, Heidelberg, Germany) supplemen



    Similar Products

    98
    ATCC aml12 cells
    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and <t>AML12</t> cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Aml12 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aml12+cells/AML12/pmc13091082-51-4-1
    Average 98 stars, based on 1 article reviews
    aml12 cells - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    94
    CLS Cell Lines Service GmbH alpha mouse liver 12 aml12 cells
    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and <t>AML12</t> cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Alpha Mouse Liver 12 Aml12 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aml12+cells/AML12+Cells/10__1016_slash_j__fbio__2026__109210-48-0-9
    Average 94 stars, based on 1 article reviews
    alpha mouse liver 12 aml12 cells - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    98
    ATCC aml12 cell lines
    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and <t>AML12</t> cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Aml12 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aml12+cells/AML12/pm42319350-49-2-9
    Average 98 stars, based on 1 article reviews
    aml12 cell lines - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    97
    Bio-Techne corporation cometassay single cell gel electrophoresis assay
    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and <t>AML12</t> cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Cometassay Single Cell Gel Electrophoresis Assay, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aml12+cells/CometAssay+Single+Cell+Gel+Electrophoresis+Assay/bio-techne+corporation___4250-050-k
    Average 97 stars, based on 1 article reviews
    cometassay single cell gel electrophoresis assay - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    86
    Procell Inc mouse liver cell line aml12
    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and <t>AML12</t> cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Mouse Liver Cell Line Aml12, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aml12+cells/aml12+cells/pm42299064-34-2-7
    Average 86 stars, based on 1 article reviews
    mouse liver cell line aml12 - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    98
    ATCC thle 2 cell culture aml12 cells
    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and <t>AML12</t> cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Thle 2 Cell Culture Aml12 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aml12+cells/THLE-2/pm42284407-316-2-26
    Average 98 stars, based on 1 article reviews
    thle 2 cell culture aml12 cells - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    86
    Procell Inc murine hepatic aml12 cells
    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and <t>AML12</t> cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Murine Hepatic Aml12 Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aml12+cells/aml12+cells/pm42269890-90-0-4
    Average 86 stars, based on 1 article reviews
    murine hepatic aml12 cells - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    98
    ATCC murine hepatocyte cell line aml12
    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and <t>AML12</t> cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Murine Hepatocyte Cell Line Aml12, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aml12+cells/AML12/pm42249087-64-1-6
    Average 98 stars, based on 1 article reviews
    murine hepatocyte cell line aml12 - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    86
    Procell Inc aml12 cell culture medium
    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and <t>AML12</t> cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Aml12 Cell Culture Medium, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aml12+cells/aml12+cells/pm42240847-74-9-13
    Average 86 stars, based on 1 article reviews
    aml12 cell culture medium - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    98
    ATCC cell culture aml12 cells aml12 cells
    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and <t>AML12</t> cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.
    Cell Culture Aml12 Cells Aml12 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aml12+cells/AML12/pm42230628-255-0-8
    Average 98 stars, based on 1 article reviews
    cell culture aml12 cells aml12 cells - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    Image Search Results


    Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and AML12 cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.

    Journal: Genes & Diseases

    Article Title: Elevated diurnal CD36 expression disrupts the bile acid synthesis rhythm leading to cholestatic liver injury and inflammation via the HMGCR/CYP7A1 axis

    doi: 10.1016/j.gendis.2025.101776

    Figure Lengend Snippet: Hepatic CD36 was elevated in patients with PBC and PSC, and CD36 displayed abnormally robust diurnal expression in mice with cholestatic liver injury. (A) Schematic representation of the study design for the clinical and animal experiments. The figure was created via BioRender.com. (B) Representative images of liver tissue subjected to immunohistochemistry staining (IHC) for CD36 in normal controls (NCs), PBC patients, and PSC patients. Scale bars: 100 or 500 μm. (C) Western blotting analysis of CD36 expression in the livers of NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (D) Relative quantification of CD36 protein expression in livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (E) mRNA expression levels of CD36 in the livers from NC ( n = 11), PBC ( n = 5), and PSC ( n = 6) patients. (F) Linear regression analysis of the correlations between hepatic CD36 mRNA expression and serum ALP, GGT, TBA, and TBIL levels. (G) mRNA expression levels of CD36 in the livers of SHAM and BDL mice ( n = 4 per time point per group) over a 24 h period. (H) Diurnal CD36 protein expression levels from Western blotting analysis of liver tissues from the SHAM and BDL mice ( n = 3 per time point per group). (I) Relative quantification of CD36 protein diurnal expression in liver tissues from the SHAM and BDL mice. (J) Double immunofluorescence staining for CD36 (green) and ALB (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (K) Double immunofluorescence staining for CD36 (green) and CK19 (red) in the SHAM and BDL mice. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. (L) Quantitative reverse transcription PCR analysis of CD36 mRNA levels in HepG2 and AML12 cells cultured for 6 h with cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA) at the indicated doses ( n = 6). All the data were presented as mean ± SEM. Group comparisons were performed via two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group. ZT0 refers to the beginning of the subjective circadian period (6:00 a.m.). The black bars indicate the dark phase from 6:00 p.m. to 6:00 a.m. PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; TBA, total bile acids; TBIL, total bilirubin; BDL, bile duct ligation; ALB, albumin; CD36, cluster of differentiation 36.

    Article Snippet: HepG2 (ATCC, USA) and AML12 cells were cultured in Dulbecco's modified Eagle medium (HyClone, USA) supplemented with 10% fetal bovine serum and 100 U/mL penicillin‒streptomycin at 37 °C in a humidified incubator containing 5% CO 2 .

    Techniques: Expressing, Immunohistochemistry, Staining, Western Blot, Quantitative Proteomics, Double Immunofluorescence Staining, Reverse Transcription, Cell Culture, Control, Ligation